Checking DMAC unusual options activity helps you spot when traders are making outsized bets on DiaMedica Therapeutics Inc before the broader market catches on. DiaMedica Therapeutics Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor DMAC unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching DMAC unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking DMAC unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and DMAC unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type I or Type II diabetes; and Phase 2/3 REMEDY2 trials for the treatment of patients with acute ischemic stroke. It is also developing DM300 that is in pre-clinical stage for the treatment of inflammatory diseases. The company was formerly known as DiaMedica Inc.
and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Catalysts rarely arrive without a footprint, and DMAC unusual options activity is often where that footprint shows up first. Our scanner tracks DiaMedica Therapeutics Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at DMAC unusual options volume on the call side or chasing put sweeps, DiaMedica Therapeutics Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.
